KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other financing activities Other financing activities Preferred Shares Issued Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue Gross Profit Leases Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Preferred Shares Issued Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Accured Receivables - Net Receivables - Other Revenue - Other Shares Issued Shares Outstanding Shares Outstanding

Vir Biotechnology (VIR) Shares Issued (2018 - 2025)

Vir Biotechnology's Shares Issued history spans 8 years, with the latest figure at $1.4 million for Q4 2025.

On a quarterly basis, Shares Issued rose 1528.09% to $1.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.8 million, a 254.05% increase, with the full-year FY2025 number at $2.8 million, up 254.05% from a year prior.
Shares Issued hit $1.4 million in Q4 2025 for Vir Biotechnology, up from -$409000.0 in the prior quarter.
Over the last five years, Shares Issued for VIR hit a ceiling of $3.7 million in Q3 2021 and a floor of -$409000.0 in Q3 2025.
Historically, Shares Issued has averaged $1.4 million across 5 years, with a median of $1.3 million in 2025.
Biggest five-year swings in Shares Issued: soared 1544.76% in 2021 and later plummeted 676.06% in 2025.
Tracing VIR's Shares Issued over 5 years: stood at $3.4 million in 2021, then fell by 28.3% to $2.5 million in 2022, then plummeted by 32.01% to $1.7 million in 2023, then crashed by 94.7% to $89000.0 in 2024, then surged by 1528.09% to $1.4 million in 2025.
Business Quant data shows Shares Issued for VIR at $1.4 million in Q4 2025, -$409000.0 in Q3 2025, and $1.2 million in Q2 2025.